MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$18,646K
EPS
-$0.42
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
7,407
General, administrative and other
9,242
Total operating expenses
16,649
Loss from operations
-16,649
Change in fair value of warrant liability
0
Change in fair value of forward contract liability
0
Change in fair value of sepa put option liability
352
Change in fair value of convertible debt
-1,773
Commitment fee expenses
0
Placement agent and tail fee expenses
0
Other income/(expense)
-619
Gain on termination of warrant and commitment fee liabilities
0
Interest income
247
Interest expense
204
Total other income/(expense)
-1,997
Net loss
-18,646
Basic EPS
-0.42
Diluted EPS
-0.42
Basic Average Shares
44,660,518
Diluted Average Shares
44,660,518
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$18,646K Loss from operations-$16,649K Total otherincome/(expense)-$1,997K Change in fair value ofsepa put option...$352K Interest income$247K Total operatingexpenses$16,649K Change in fair value ofconvertible debt-$1,773K Otherincome/(expense)-$619K Interest expense$204K General, administrativeand other$9,242K Research and development$7,407K

FibroBiologics, Inc. (FBLG)

FibroBiologics, Inc. (FBLG)